Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
Stockchase Opinions

Glenn Paradis, BA, CFAApplera-Celera GenCRADON'T BUYMay 04, 2001

Business model not set out yet. Risky.
$41.00

Stock price when the opinion was issued

biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.